|
|
 |
R & D
NociPharm’s research and development division is lead by experienced and proven management team, who on average have more than 10 years of research and development, approval and launch experience in the pharmaceutical industry. Since our founding, NociPharm has placed it’s own resources, talent and expertise on the line to develop value-added products that benefit consumers.
Through rigorous internal research and development, NociPharm has accomplished an expanding line of cosmeceutical and over-the-counter products that have no competitor products presently known. NociPharm is committed to finding ways to deliver superior products with greater safety, stability and effectiveness. Our focus on developing products with a natural base is a conscious effort to circumvent unwanted side effects often associated with new, synthetic molecules.
NociPharm has entered into productive research contracts with outstanding research organizations of specific strategic importance to the Company. This includes productive research at the Defense Research & Development Canada Institute (DRDC, Toronto Downsview), and the Canadian Institute for Food Safety (University of Guelph).
NociPharm’s long-term objective is to determine the mechanism and scope of its H+ technology on nociceptor and inflammatory pathways and diseases, and to extend this knowledge for rational design of broader follow-up products in the prescription drug market. We bring to this endeavour not only our wide-ranging talents but also the resources of a company devoted to the scientific enterprise.
|
|
|
|
